# Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms

> **NCT00497523** · PHASE3 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 283 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** Beclomethasone dipropionate
- **DRUG:** Beclomethasone dipropionate/Salbutamol combination
- **DRUG:** Salbutamol

## Key facts

- **NCT ID:** NCT00497523
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497523, "Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00497523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*